Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.250
-0.050 (-2.17%)
At close: Mar 31, 2025, 4:00 PM
2.217
-0.033 (-1.47%)
After-hours: Mar 31, 2025, 4:22 PM EDT
Mereo BioPharma Group Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$7.71
Upside
+242.67%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Initiates $7 | Buy | Initiates | $7 | +211.11% | Mar 27, 2025 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +211.11% | Mar 26, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +211.11% | Mar 18, 2025 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +211.11% | Jan 13, 2025 |
LifeSci Capital | LifeSci Capital | Buy Initiates $10 | Buy | Initiates | $10 | +344.44% | Dec 24, 2024 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +211.11% | Dec 17, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +211.11% | Dec 6, 2024 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +211.11% | Nov 12, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +211.11% | Oct 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +211.11% | Sep 16, 2024 |
Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +211.11% | Aug 13, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +211.11% | Jul 22, 2024 |
Leerink Partners | Leerink Partners | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +255.56% | Jun 20, 2024 |
Baird | Baird | Buy Initiates $8 | Buy | Initiates | $8 | +255.56% | Jun 13, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +211.11% | Jun 12, 2024 |
Needham | Needham | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +211.11% | Jun 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.